SCHEMBL6497045

SCHEMBL6497045

NC(=O)C(=O)Oc1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccccc23)ccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.50
PDGFRB P09619 3/20 0.50
KIT P10721 3/20 0.50
FLT4 P35916 3/20 0.50
MAP3K20 Q9NYL2 2/20 0.50
ILK Q13418 1/20 0.50
FLT1 P17948 9/20 0.46
CSF1R P07333 2/20 0.44
CIT O14578 1/20 0.43
EGFR P00533 1/20 0.43
HLA-A P04439 1/20 0.43
RET P07949 1/20 0.43
PDGFRA P16234 1/20 0.43
RPS6KB1 P23443 1/20 0.43
FRK P42685 1/20 0.43
CDK8 P49336 1/20 0.43
DDR1 Q08345 1/20 0.43
STK3 Q13188 1/20 0.43
PTK6 Q13882 1/20 0.43
MAP3K19 Q56UN5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6602572 0.87 KDR (0.56) KDRPDGFRBKITFLT4MAP3K20
SCHEMBL6505180 0.86 KDR (0.63) KDRPDGFRBKITFLT4MAP3K20
Hydrochloric Acid SCHEMBL6505932 0.85 KDR (0.62) KDRPDGFRBKITFLT4MAP3K20
SCHEMBL6482138 0.85 KDR (0.60) KDRPDGFRBKITFLT4MAP3K20
Hydrochloric Acid SCHEMBL6479719 0.84 KDR (0.59) KDRPDGFRBKITFLT4MAP3K20
SCHEMBL6497078 0.81 KDR (0.58) KDRPDGFRBKITFLT4MAP3K20
SCHEMBL6600180 0.80 KDR (0.52) KDRPDGFRBKITFLT4MAP3K20
Hydrochloric Acid SCHEMBL6600046 0.80 KDR (0.51) KDRPDGFRBKITFLT4MAP3K20
SCHEMBL6474476 0.80 KDR (0.76) KDRPDGFRBKITFLT4MAP3K20
SCHEMBL6494487 0.78 KDR (0.66) KDRPDGFRBKITFLT4MAP3K20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903101-B1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity BAYER PHARMACEUTICALS CORPORATION (US) 2005-06-07 US claimed
EP-1208096-B1 SUBSTITUTED PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY BAYER AG (US) 2004-04-28 EP claimed
US-6903101-B1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity BAYER PHARMACEUTICALS CORPORATION (US) 2005-06-07 US disclosed
EP-1208096-B1 SUBSTITUTED PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY BAYER AG (US) 2004-04-28 EP disclosed